ARTICLE | Clinical News
PredicTOR diagnostic data
September 24, 2012 7:00 AM UTC
An exploratory study analyzing tumor samples surgically removed prior to treatment with Herceptin trastuzumab from 45 patients with HER2-positive breast cancer showed that 20/20 GeneSystems' PredicTOR...